INTRODUCTION {#sec1-1}
============

Excipients are additives used to convert active pharmaceutical ingredients into a suitable dosage form. New and modified excipients continue to emerge with a better drug delivery performance. Excipients of natural origin are of particular interest to formulation scientists because of their reliability and sustainability. In recent years, natural substances have evoked tremendous interest due to their diverse pharmaceutical applications, such as, their diluent, binder, and disintegrant qualities in tablets. Plant products are therefore an attractive alternative to synthetic products because of biocompatibility, low toxicity, environmental friendliness, and low price, compared to synthetic products. Excipients from natural sources are also generally non-polluting renewable sources for the sustainable supply of cheaper pharmaceutical products.\[[@ref1]--[@ref3]\]

Difficulty in swallowing is a common problem of all age groups, especially geriatric and pediatric patients, due to the physiological changes associated with these groups, tending toward non-compliance and ineffective therapy.\[[@ref4]\] Recent advances in novel drug delivery systems (NDDS) have aimed to enhance the safety and efficacy of drug molecules by formulating a convenient dosage form for administration, and they have also aimed to achieve better patient compliance. One such approach is a fast disintegrating tablet. Advantages of this drug delivery system includes accuracy of dosage, easy portability, it is an alternative to the liquid dosage form, and is ideal for pediatric and geriatric patients, with a rapid onset of action.\[[@ref5]--[@ref8]\]

The present study was carried out to study the disintegrant property of *Hordeum vulgare* hull in comparison with cross carmellose sodium by formulating fast disintegrating tablets. Diclofenac sodium was used as a model drug in the formulations. The concept of formulating fast disintegrating tablets offered a suitable and practical approach for serving the desired objective of faster disintegration, and the dissolution characteristics with potential increased bioavailability.

MATERIALS AND METHODS {#sec1-2}
=====================

Materials {#sec2-1}
---------

Hull was collected from the seeds of the *Hordeum vulgare* (*Fam: Poaceae*), which was purchased from the local market and treated suitably. The seeds were authenticated by Botanical Survey of India, Jodhpur. Microcrystalline cellulose was purchased from Ases Chemicals, Jodhpur, and Sodium starch glycolate was purchased from Loba Chemie Pvt. Ltd, Mumbai. All other chemicals and reagents were of analytical grade.

Collection, isolation, and treatment of hull {#sec2-2}
--------------------------------------------

The seeds of the *Hordeum vulgare*, having the complete hull, were purchased from the local market and moistened with the mixture of water and ethanol for 45 to 60 minutes. Next, the damp seeds with the hull were crushed in an iron pestle mortar with mild impact. The contents were air dried and then the outer hull was separated and collected. The collected hull was subjected to grinding in an electric grinder and passed through sieve No. 100. The powder was percolated with 70% ethanol for 48 hours and the alcohol was collected, with continuous addition of fresh menstrum, until no more pink color appeared in extract. The hull was initially dried for 12 hours at room temperature and then for 48 hours at 50°C. The dried hull powder was stored in an air tight container.

Preparation of fast disintegrating tablets {#sec2-3}
------------------------------------------

Different tablet batches (F~1~S, F~2~S, F~3~H, F~4~H, F~5~C, and F~6~C) were prepared as per the formula given in [Table 1](#T1){ref-type="table"}. All the ingredients were passed through the \#60 mesh separately. Accurately weighed quantities of Diclofenac sodium, microcrystalline cellulose, mannitol, and other excipients were mixed in geometrical order. This blend was granulated with an alcoholic solution of PVP (10% w/v in 50% ethanol), and passed through a \#10 mesh. The granules were air-dried, passed through a \#22 mesh, and lubricated with talc and magnesium stearate. The granules were evaluated for various parameters and the results are summarized in [Table 2](#T2){ref-type="table"}. The tablets were compressed using 9 mm round concave punches to get tablets of 300 mg weight on eight station rotary tablet machines (Hardik Engineering, Ahmedabad).

###### 

Composition of different batches of fast disintegrating tablets
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Evaluation of granules
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Evaluation of granules {#sec2-4}
----------------------

The granules of all the batches were evaluated for different parameters like bulk density, tapped density, Carr\'s index, Hausner ratio, and angle of repose. Bulk density and tapped density were determined using the bulk density apparatus. A pre-weighed quantity of granules was transferred to the measuring cylinder and the bulk density was calculated. Next, the granules were subjected to 100 tappings and the tapped density was calculated.

Carr\'s index and Hausner ratio of the granules was calculated using the following formulae (D~t~ -- D~b~) %100/D~t~ and D~t~/D~b~, respectively. Where D~t~ was the bulk density of the granules and D~b~ was the tapped density of the granules. The angle of repose indicated the flow property of granules. The granules were subjected to flow through a funnel and a pile was obtained. The angle of repose was calculated using the following formula \[tan θ = h/r\], where θ was the angle of repose and h and r were the height and radius of the pile, respectively.\[[@ref9][@ref10]\]

Evaluation of tablets {#sec2-5}
---------------------

Twenty tablets were randomly selected from each batch and individually weighed. The average weight of these selected tablets was calculated, and the individual tablet weight was compared with the average tablet weight.\[[@ref11]\] The thickness and crushing strength (Hardness) of the tablets were measured by using the Vernier Calipers and Monsanto hardness tester, respectively. A tablet hardness of 4--5 kg was considered adequate for mechanical stability. All the determinations were made in triplicate and the average value was calculated \[[Table 3](#T3){ref-type="table"}\].

###### 

Evaluation of tablets
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### Friability {#sec3-1}

The friability test was performed to assess the effect of friction and shocks, which could often cause the tablet to chip, cap, or break. The friability of the tablets was measured by using the Roche friabilator, at 25 rpm, for four minutes. The weight of 20 tablets before and after completion of the test was recorded and the friability was calculated using the following formula (W~0~ -- W) %100/W~0~, where W~0~ is the weight of tablets before rotation and W is the weight of tablets after rotation. All the determinations were made in triplicate and the average value was calculated.\[[@ref12]\]

### Drug content uniformity {#sec3-2}

For the drug content uniformity test, ten tablets were weighed and powdered. The powder, equivalent to 25 mg Diclofenac Sodium, was taken in a 100-ml volumetric flask and dissolved in methanol. The volume was made up to the mark with methanol. From this solution, 5 ml was withdrawn, diluted to 100 ml with methanol, and was filtered through Whatman No. 40. The drug content in the filtrate was determined by measuring the absorbance at 246.5 nm. The mean percent drug content was calculated as an average of three determinations.\[[@ref13]\]

### Wetting time {#sec3-3}

The wetting time of the tablets can be measured using a simple procedure. A piece of tissue paper folded twice was placed in a glass petridish of 10 cm internal diameter and 10 ml of amaranth solution was added to the petridish. A tablet was placed carefully on the surface of the tissue paper. The time required for water to reach the upper surface of the tablet is noted as the wetting time. All the determinations were made in triplicate and the average value was calculated.\[[@ref14][@ref15]\]

### Water absorption ratio {#sec3-4}

A piece of tissue paper folded twice was placed in a glass petridish of 10 cm internal diameter and 10 ml of amaranth solution was added to the petridish. A pre-weighed tablet was placed carefully on the surface of the tissue paper. After complete wetting, the tablet was again weighed. The water absorption ratio was determined by the following formula (W~b~ -- W~a~)%100/W~a~. Where W~a~ was the weight of the tablet before water absorption and W~b~ was the weight of tablet after water absorption. All the determinations were made in triplicate and the average value was calculated.\[[@ref16]\]

### In vitro dispersion time {#sec3-5}

Three tablets per batch were evaluated for *in vitro* dispersion time. For determination of *in vitro* dispersion time, one tablet was placed in a beaker containing distilled water, at 37 ± 0.5°C, and the time required for the complete dispersion was determined.\[[@ref17]\]

### In vitro dissolution study {#sec3-6}

*In vitro* dissolution of the fast disintegrating tablets was studied in United State Pharmacopoeia dissolution testing apparatus II (Electrolab TDT 08L), employing a paddle stirrer at 50 rpm using 500 ml of Phosphate Buffer (pH 6.8), at 37° ± 0.5°C, as the dissolution medium. One tablet was used in each test. Aliquots of the samples were withdrawn at specified intervals of time. The volume withdrawn at each time interval was replaced with a fresh dissolution medium of the same quantity. The samples were filtered and analyzed for drug content by measuring the absorbance at 242.5 nm, using a UV/VIS spectrophotometer (CECIL CE-7400).\[[@ref18]\]

### Stability testing {#sec3-7}

Short-term stability studies on the promising formulations (F~2~S, F~4~H, and F~6~C) were carried out by storing the tablets in an amber colored rubber stoppered vial at 40°C/75% RH over a period of 45 days. At the interval of 15 days, the tablets were visually examined for any physical changes, changes in drug content, and *in-vitro* dispersion time.\[[@ref19]\]

RESULTS AND DISCUSSION {#sec1-3}
======================

Fast disintegrating tablets were prepared by the wet granulation technique employing *H. vulgare* hull, sodium starch glycolate, and cross carmellose sodium as superdisintegrants, in different concentrations, along with microcrystalline cellulose. Mannitol was used as a diluent in the formulation. A total of six formulations were designed, prepared, and evaluated.

For each designed formulation, the granules were evaluated for micromeritic properties shown in [Table 2](#T2){ref-type="table"}. Bulk density was found to be between 0.263 and 0.364 gm/cm^3^ and tapped density between 0.303 and 0.432 gm/cm^3^, for all formulations. From the density data, the Carr\'s index was calculated and was found to be within the range of 12.68 to 14.86%. The value of the angle of repose was found to be in the range of 30.41° to 34.87°, showing a good flow property of granules. The Hausner ratio was found to be below 1.2 for all the formulations.

The prepared tablets of all the formulations possessed sufficient hardness in the range of 4.33 to 5.33 kg/cm^2^. Percent friability below 1% was an indication of the good mechanical resistance of the tablets. As the granules were free flowing (angle of repose 30° -- 40° and Carr\'s index \<15%) the tablets obtained were of uniform weight, with acceptable variations, as per IP specifications, that is, below ±7.5%. All the formulations were found to be promising and displayed an *in vitro* dispersion time within the range of 22.4 seconds to 41 seconds, which facilitated their fast dispersion. The formulation containing hull was showing very fast disintegration when compared with those formulations having sodium starch glycolate. The drug content was found to be in the range of 93.93 to 99.84%, which was within acceptable limits. Although the water absorption ratios for the F~3~H and F~4~H batches were found to be more than 60%, the wetting time for these formulations was found to be much higher when compared to the wetting time of those formulations having sodium starch glycolate and cross carmellose sodium as superdisintegrants.

*In vitro* dissolution studies on all the formulations were carried out in the Phosphate buffer (pH 6.8). Various dissolution parameter values of the percent drug, dissolved in 5, 10, 15, and 30 minutes, are shown in [Table 4](#T4){ref-type="table"} and the dissolution profiles depicted in [Figure 1](#F1){ref-type="fig"}. This data also reveals that the formulation F~4~H displays almost similar results as shown by formulations F~1~S and F~2~S. Short-term stability studies of the formulations F~2~S, F~4~H, and F~6~C are presented in Tables [5](#T5){ref-type="table"}--[7](#T7){ref-type="table"} indicate that there are no significant changes in drug content and *in-vitro* dispersion time at the end of 45 days.

###### 

*In vitro* release profile of drug
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![*In vitro* cumulative drug release versus time profiles. Plots showing percent cumulative drug release in 0.1N HCl from F~1~S formulation (-♦-); F~2~S formulation (-x-); F~3~H formulation(-■-); F~4~H formulation (-♦-); F~5~C formulation (-▲-); and F~6~C formulation (-●-)](JYPharm-3-211-g005){#F1}
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Stability data of F~2~S formulation at 40°C /75% RH
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Stability data of F~4~H formulation at 40°C /75% RH
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###### 

Stability data of F~6~C formulation at 40° C/75% RH
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Overall, formulations F~3~H and F~4~H containing *H. vulgare* hull (4% w/w and 6% w/w, respectively) and 35% w/w microcrystalline cellulose were found to be promising and have shown an *in vitro* dispersion time of approx 36 seconds and 33 seconds, respectively. The experimental data also reveals that the results obtained from the *H. vulgare* hull are comparable and even slightly better than those of sodium starch glycolate and cross carmellose sodium.
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